Barrington Nutritionals said they are connecting with high-quality ingredient producers, innovators and health and wellness product manufacturers to expand VivoMega's position in the functional food, nutraceutical and pharmaceutical sectors.
VivoMega oils, which focuses on high-purity and high concentrations, will be used in fish oil applications and finished products.
Christopher Hachey, US Business Development Manager at GC Rieber, told us Barrington Nutritionals will help support the distribution of these new omega-3 oils along with their existing line of omega-3 oils.
Mexico market
The collaboration between Barrington Nutritionals and GC Rieber is “strictly an effort to expand GC Rieber’s business-to-business reach in the US and Mexico,” Hachey noted.
Commenting on why Mexico is such a key market for the duo, Hachey said, “Mexico is part of the North America market and we are interested in exploring the new opportunities there.”
When considering supplements, quality, and claims, Hachey explained that Mexican consumers tend to focus on clinically-based science and feel confident that the products “do what they claim to do for their health and wellness.”
Quality omega-3 concentrates
Providing insights on what amounts to high-quality concentrates for omega-3 solutions, the company noted that its oils are more concentrated, allowing for smaller capsule size to meet compliance demands from customers focused on the dosage, sensory and bioavailability of the supplement.
When looking at how increasing quality and concentrate impacts nutrition, Hachey said that human clinical trials will allow the company to provide specific concentrations of EPA and DHA for specific health indications to better target specific health concerns and needs. Hachey said GC Rieber’s focus is to provide specific omega-3 oils for specific health indications based on medical clinical trials. “These new omega-3 oils are all based on clinical trial results via different health indications,” he said, adding that he “hopes to increase awareness of GC’s high quality and potent omega-3 oils as well as the clinical evidence backing our claims”.
New production facility
After recently opening a new production unit in Norway, Hachey explained that its addition has “allowed the company to expand its current offerings with a new high concentrated omega-3.”
By leveraging modern production technology and equipment at its new facility, GC Rieber Oils noted it is able to produce some of the most potent, stable and pure omega-3 concentrates in the nutraceutical and supplements markets.
The company also recently increased its plant’s production capacity by 60%, along with including high docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) fish oils, up to 800mg/g.
Spearheading business growth
GC Rieber Oils CEO Jan Roger Bjerkestrand said that it teamed up with Barrington Nutritionals because of their multiple warehouse locations, logistical expertise and reputation for excellent service.
Stu Gelbard, President of Barrington Nutritionals said it selected manufacturing partner GC Rieber Oils for its “quality, innovation, sustainability and reliability with its massive crude fish oil tank farm inventory."
In the next step in its business growth strategy in both Mexico and the US, Bjerkestrand said GC Rieber Oils will add Barrington’s marketing and sales support to its commercial activities, and added that the partnership will help GC Rieber Oils fulfil its vision to deliver quality concentrates for Omega-3 solutions across the world.
